Home 
 News 
     



The Problem     The Solution

Worldwide, 600,000 infants and children die each year from rotavirus infections, a disease that is highly preventable with an oral vaccine. A vaccine that has demonstrated efficacy in preventing rotavirus infections has not been available.

 

RotaShield is an effective, oral vaccine to prevent rotavirus-related diarrheal diseases in children. BIOVIRx intends to market the vaccine worldwide, where this product could save millions of lives and yield significant healthcare benefits.







Delivering a legacy of health to global needs.